BRPI0914805B8 - método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição - Google Patents
método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composiçãoInfo
- Publication number
- BRPI0914805B8 BRPI0914805B8 BRPI0914805A BRPI0914805A BRPI0914805B8 BR PI0914805 B8 BRPI0914805 B8 BR PI0914805B8 BR PI0914805 A BRPI0914805 A BR PI0914805A BR PI0914805 A BRPI0914805 A BR PI0914805A BR PI0914805 B8 BRPI0914805 B8 BR PI0914805B8
- Authority
- BR
- Brazil
- Prior art keywords
- cells
- suspension
- scldk
- cell culture
- growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
- C12N2760/16152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16311—Influenzavirus C, i.e. influenza C virus
- C12N2760/16351—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6182808P | 2008-06-16 | 2008-06-16 | |
US61/061,828 | 2008-06-16 | ||
PCT/US2009/046721 WO2009155168A1 (en) | 2008-06-16 | 2009-06-09 | Method of replicating viruses in suspension cultures of dog kidney cells |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0914805A2 BRPI0914805A2 (pt) | 2015-10-13 |
BRPI0914805B1 BRPI0914805B1 (pt) | 2020-11-17 |
BRPI0914805B8 true BRPI0914805B8 (pt) | 2021-05-25 |
Family
ID=40937407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0914805A BRPI0914805B8 (pt) | 2008-06-16 | 2009-06-09 | método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição |
Country Status (9)
Country | Link |
---|---|
US (2) | US20110097785A1 (pt) |
EP (1) | EP2291517A1 (pt) |
JP (2) | JP2011524182A (pt) |
AR (1) | AR072150A1 (pt) |
BR (1) | BRPI0914805B8 (pt) |
CA (1) | CA2726513C (pt) |
MX (1) | MX2010013937A (pt) |
TW (1) | TW201012930A (pt) |
WO (1) | WO2009155168A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2829774C (en) | 2011-03-14 | 2019-09-24 | National Research Council Of Canada | Method of viral production in cells |
KR101370512B1 (ko) * | 2013-06-07 | 2014-03-06 | 재단법인 목암생명공학연구소 | 무단백 배지에서 부유 배양되는 mdck 유래 세포주 및 상기 세포주를 이용하여 바이러스를 증식시키는 방법 |
KR102453351B1 (ko) | 2017-07-05 | 2022-10-07 | 에스케이바이오사이언스(주) | 인플루엔자 백신용 바이러스 씨드 스톡의 제조 방법 |
US20220080040A1 (en) | 2018-12-21 | 2022-03-17 | Intervet Inc. | Serum free intracellular pathogen vaccine |
CN116731983A (zh) * | 2023-08-15 | 2023-09-12 | 金宇保灵生物药品有限公司 | 采用mdck细胞连续培养犬副流感病毒的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4500513A (en) * | 1979-05-15 | 1985-02-19 | Miles Laboratories, Inc. | Influenza vaccine production in liquid cell culture |
CA1122527A (en) * | 1979-05-15 | 1982-04-27 | Karen K. Brown | Influenza vaccine production in liquid cell culture |
USRE33164E (en) * | 1979-05-15 | 1990-02-13 | Mobay Corporation | Influenza vaccine production in liquid cell culture |
DE19612966B4 (de) * | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
US20040171152A1 (en) | 1996-10-10 | 2004-09-02 | Invitrogen Corporation | Animal cell culture media comprising non-animal or plant-derived nutrients |
US20040087020A1 (en) | 1997-05-28 | 2004-05-06 | Chiron S.P.A. | Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin |
US20060286668A1 (en) | 1999-04-30 | 2006-12-21 | Invitrogen Corporation | Animal-cell culture media comprising non-animal or plant-derived nutrients |
AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
AU3604201A (en) * | 2000-03-03 | 2001-09-12 | Chemo Sero Therapeut Res Inst | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
US7481781B2 (en) * | 2000-11-17 | 2009-01-27 | Gendel Limited | Ultrasound therapy |
PL214284B1 (pl) | 2002-07-09 | 2013-07-31 | Baxter Healthcare Sa | Sposób wytwarzania wirusa oraz sposób wytwarzania immunogennej kompozycji zawierajacej wirusa albo antygen wirusa |
US7160699B2 (en) | 2003-09-25 | 2007-01-09 | Allergan, Inc. | Media for clostridium bacterium and processes for obtaining a clostridial toxin |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
JP4693839B2 (ja) * | 2005-03-10 | 2011-06-01 | 共立製薬株式会社 | 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法 |
-
2009
- 2009-05-26 TW TW098117455A patent/TW201012930A/zh unknown
- 2009-06-09 CA CA2726513A patent/CA2726513C/en active Active
- 2009-06-09 EP EP09767478A patent/EP2291517A1/en not_active Withdrawn
- 2009-06-09 US US12/999,105 patent/US20110097785A1/en not_active Abandoned
- 2009-06-09 JP JP2011514697A patent/JP2011524182A/ja active Pending
- 2009-06-09 BR BRPI0914805A patent/BRPI0914805B8/pt active IP Right Grant
- 2009-06-09 WO PCT/US2009/046721 patent/WO2009155168A1/en active Application Filing
- 2009-06-09 MX MX2010013937A patent/MX2010013937A/es not_active Application Discontinuation
- 2009-06-16 AR ARP090102168A patent/AR072150A1/es unknown
-
2014
- 2014-12-10 JP JP2014249651A patent/JP6110357B2/ja active Active
-
2015
- 2015-07-17 US US14/802,087 patent/US9441207B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2291517A1 (en) | 2011-03-09 |
JP2015083008A (ja) | 2015-04-30 |
CA2726513A1 (en) | 2009-12-23 |
US20110097785A1 (en) | 2011-04-28 |
BRPI0914805B1 (pt) | 2020-11-17 |
WO2009155168A1 (en) | 2009-12-23 |
US9441207B2 (en) | 2016-09-13 |
JP2011524182A (ja) | 2011-09-01 |
AR072150A1 (es) | 2010-08-11 |
US20150322411A1 (en) | 2015-11-12 |
CA2726513C (en) | 2018-02-20 |
JP6110357B2 (ja) | 2017-04-05 |
BRPI0914805A2 (pt) | 2015-10-13 |
MX2010013937A (es) | 2011-01-21 |
TW201012930A (en) | 2010-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR069956A1 (es) | Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas | |
EA200801221A1 (ru) | Вирусные вакцины, полученные из клеток, с низкими уровнями остаточной клеточной днк | |
BR112017007770A2 (pt) | cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc. | |
MX2007005132A (es) | Medios libres de proteina animal para cultivo de celulas. | |
MX2019002495A (es) | Metodos para producir virus para la produccion de vacunas. | |
EA201491526A1 (ru) | Способ культивирования бычьих и свиных сперматогониальных стволовых клеток без использования клеток-фидеров | |
NO20054124L (no) | Dyre-fri celle kultur metode | |
BR112015018493A2 (pt) | Linhagens celulares para produção de vírus e métodos de uso | |
WO2010147395A3 (en) | Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same | |
EA201171018A1 (ru) | Биореактор для культивирования клеток млекопитающих | |
BR112015022770A8 (pt) | meio e sistema de cultivo da célula livre de xenógeno, livre de albumina, forma concentrada, métodos de diferenciação de células-tronco pluripotentes humanas, para a produção de mesenquimoangioblastos e sistema definido de cultivo da célula para diferenciação hematoendotelial das células- tronco pluripotentes humanas | |
PL1646715T3 (pl) | Wytwarzanie pokswirusów za pomocą linii adherentnych lub nieadherentnych komórek ptasich | |
ATE482267T1 (de) | Tierzellen und verfahren für die replikation von influenza viren | |
BRPI0516221A (pt) | método de produção de vìrus de uma cultura de células, composição, e, método de produção de reovìrus infeccioso | |
AR079707A1 (es) | Celula aislada de ovario de hamster chino util para la produccion de anticuerpos terapeuticos | |
BRPI0914805B8 (pt) | método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição | |
NZ611531A (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
BR112018010499A2 (pt) | método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, população de células in vitro, método para produzir uma população de células, e população de células | |
PA8813901A1 (es) | Paramixovirus oncolíticos atenuados que codifican citoquinas de aves | |
WO2012014207A3 (en) | Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles | |
AR079710A1 (es) | Proceso para el cultivo de celulas adherentes | |
IN2014CN03077A (pt) | ||
EA201690232A1 (ru) | Генетически стабильный онколитический рнк вирус, способ его производства и применения | |
AR069885A1 (es) | Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional | |
NZ629709A (en) | Compounds and methods for improving plant performance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: C12N 7/00 (2006.01) |
|
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/06/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |